跳至主要内容
临床试验/ISRCTN14817328
ISRCTN14817328已完成未知

The PRIME Breast Cancer Trial: Postoperative Radiotherapy in Minimum-Risk Elderly

Department of Health (UK)0 个研究点目标入组 255 人开始时间: 2002年8月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
255

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Age of 65 years or more, receiving adjuvant endocrine therapy
  • 2. Medically suitable to attend for all treatments and follow ups
  • 3. Histologically confirmed unilateral breast cancer of Tumour, Metastasis, Node (TMN) stages T0-2
  • 4. No axillary node involvement on histological assessment
  • 5. Had breast conserving surgery with complete excision on histological
  • 6. Able and willing to give informed consent

排除标准

  • 1. Past history of pure in situ carcinoma of either breast or previous or concurrent malignancy within the past five years other than non-melanomatous skin cancer or carcinoma in situ of cervix
  • 2. Grade III cancer with lymphatic/vascular invasion (because of higher risk of local recurrence)

研究者

发起方
Department of Health (UK)

相似试验